Faculty, Staff, and researchers

Our People

Featured researcher

Paul Aisen, MD

Contribution of Alzheimer’s biomarkers and risk factors to cognitive impairment and decline across the Alzheimer’s disease continuum Alzheimers Dement.

Using the Alzheimer’s Disease Neuroimaging Initiative to improve early detection, diagnosis, and treatment of Alzheimer’s disease Alzheimers Dement.

The case for low-level BACE1 inhibition for the prevention of Alzheimer disease Nat Rev Neurol.

Learn More

Leadership & Faculty

Paul Aisen, MD

Professor of Neurology, Founding Director of Alzheimer's Therapeutic Research Institute

Research Areas

Alzheimer’s disease (AD) clinical trial design
Remote assessment of AD risk
Primary prevention of AD

Michael Rafii, MD, PhD

Professor of Neurology, Medical Director of Alzheimer's Therapeutic Research Institute

Research Areas

Clinical Trials for Alzheimer’s disease in Down syndrome
Biomarkers of Alzheimer’s disease in Down syndrome
AD Clinical Trial Design and Conduct

Rema Raman, PhD

Professor of Neurology; Director, Section of Biostatistics & Section of Participant Recruitment & Retention Alzheimer's Therapeutic Research Institute

Research Areas

Biostatistics
Clinical trial design, conduct and analysis
Participant recruitment and retention science

Professor of Physiology and Neuroscience and the W.M. Keck Endowed Professor in Medicine, Director Neuroscience Translational Research Division and Biomarker Laboratory and Biorepository Director, Alzheimer's Therapeutic Research Institute

Research Areas